You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

VASERETIC Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Vaseretic, and what generic alternatives are available?

Vaseretic is a drug marketed by Bausch and is included in one NDA.

The generic ingredient in VASERETIC is enalapril maleate; hydrochlorothiazide. There are twenty-seven drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the enalapril maleate; hydrochlorothiazide profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for VASERETIC?
  • What are the global sales for VASERETIC?
  • What is Average Wholesale Price for VASERETIC?
Summary for VASERETIC
Drug patent expirations by year for VASERETIC
Drug Prices for VASERETIC

See drug prices for VASERETIC

US Patents and Regulatory Information for VASERETIC

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bausch VASERETIC enalapril maleate; hydrochlorothiazide TABLET;ORAL 019221-003 Jul 12, 1995 AB RX Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Bausch VASERETIC enalapril maleate; hydrochlorothiazide TABLET;ORAL 019221-001 Oct 31, 1986 AB RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for VASERETIC

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bausch VASERETIC enalapril maleate; hydrochlorothiazide TABLET;ORAL 019221-001 Oct 31, 1986 ⤷  Sign Up ⤷  Sign Up
Bausch VASERETIC enalapril maleate; hydrochlorothiazide TABLET;ORAL 019221-003 Jul 12, 1995 ⤷  Sign Up ⤷  Sign Up
Bausch VASERETIC enalapril maleate; hydrochlorothiazide TABLET;ORAL 019221-001 Oct 31, 1986 ⤷  Sign Up ⤷  Sign Up
Bausch VASERETIC enalapril maleate; hydrochlorothiazide TABLET;ORAL 019221-003 Jul 12, 1995 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for VASERETIC

See the table below for patents covering VASERETIC around the world.

Country Patent Number Title Estimated Expiration
New Zealand 192312 CARBOXYALKYL DIPEPTIDE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS ⤷  Sign Up
Canada 1262684 DERIVES AMINOACIDES ASSOCIES A DES AGENTS DIURETIQUES (AMINOACID DERIVATIVES COMPOSITION IN ASSOCIATION WITH DIURETIC AGENTS) ⤷  Sign Up
Canada 1275350 LISINOPRIL (LISINOPRIL) ⤷  Sign Up
Spain 8106134 ⤷  Sign Up
Czechoslovakia 237327 METHOD OF PREPARATION OF CARBOXYALKYL DIPEPTIDE ⤷  Sign Up
Finland 793799 ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.